Kineta, Inc. (YMTX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Kineta, Inc. (YMTX)
Go deeper and ask any question about YMTX
Company Performance
Current Price
as of Sep 13, 2024$0.77
P/E Ratio
N/A
Market Cap
$9.42M
Description
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Mercer Island, WA.
Metrics
Overview
- HQMercer Island, WA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerYMTX
- Price$0.768+2.40%
Trading Information
- Market Cap$9.42M
- Float65.57%
- Average Daily Volume (1m)71,337
- Average Daily Volume (3m)629,280
- EPS-$1.81
Company
- RevenueN/A
- Rev Growth (1yr)-100.00%
- Net Income-$2.60M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$2.59M
- EV$6.82M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Factset Street Account